Liu Lab
The Geoffrey Liu laboratory is a multidisciplinary, collaborative translational laboratory that seeks to improve outcomes in cancer. The laboratory has four main programs and a multi-level training program:
AMP-PEL program:
stands for Applied Molecular, Pharmacoepidemiologic, Pharmacogenomic, and Epidemiologic Laboratory, and focuses on identifying and validating cancer biomarkers:
-
Project 1: OPTIMAL:Organoids to guide Post-resistanceTherapyIn driver MutAtedLung cancers which utilizes the PALMS(PAtient-derivedLung cancer ModelS) gold cohort of data and samples
-
Project 2: human population studies (COS-ILCCO: Clinical Outcomes Studies of the International Lung Cancer Consortium Studies of Clinical Outcomes) and understanding
-
Project 3: developing improved patient phenotyping of symptoms and toxicities: (2BLAST: Biostatistical and Bioinformatic Longitudinal Assessment of Symptoms and Toxicities)
-
Project 4: PRALINES:PRincessMargaret Adenocarcinoma of Lung cancer InNeversmokErsStudy, which utilizes the ALINE (Adenocarcinoma of Lung cancer InNeversmokEr) gold cohort of data and samples
-
Project 5: CPHIN Lung KSP:CanadianPersonalized Healthcare Innovation Network Lung cancer Kick Start Program
CALIBRE program:
stands for Clinical And LIquid biopsy, Breathomics, and Radiomics for Early detection of Cancer
HANG-OUT program:
stands for Head And Neck cancer network for Genetics, Observational oUtcomes, and Toxicities: A combined OPTIMAL and ON-PROST initiative
-
Project 1: GENE-SMOKE:
Genetics of Smoking Outcomes and Knowledge Effects
-
Project 2: GENE-LAST:
Genetics of Long and Short-term Toxicities
-
Project 3: VOYAGER consortium: humanpapilloma Virus, Oral and oropharYngeal cAncer, GEnomicsand suRvival
-
Project 4: ENHANCE consortium: International Head And Neck Cancer Epidemiology Consortium